Merck Total Long Term Liabilities 2010-2024 | MKKGY
Merck total long term liabilities from 2010 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
- Merck total long term liabilities for the quarter ending June 30, 2024 were $12.199B, a 15.01% decline year-over-year.
- Merck total long term liabilities for 2023 were $14.114B, a 2.99% increase from 2022.
- Merck total long term liabilities for 2022 were $13.704B, a 14.29% decline from 2021.
- Merck total long term liabilities for 2021 were $15.99B, a 9.98% decline from 2020.
Merck Annual Total Long Term Liabilities
(Millions of US $) |
| 2023 |
$14,114 |
| 2022 |
$13,704 |
| 2021 |
$15,990 |
| 2020 |
$17,762 |
| 2019 |
$15,742 |
| 2018 |
$13,153 |
| 2017 |
$14,605 |
| 2016 |
$16,726 |
| 2015 |
$17,499 |
| 2014 |
$10,113 |
| 2013 |
$7,771 |
| 2012 |
$8,574 |
| 2011 |
$10,119 |
| 2010 |
$ |
| 2009 |
$ |
Merck Quarterly Total Long Term Liabilities
(Millions of US $) |
| 2024-06-30 |
$12,199 |
| 2024-03-31 |
$12,477 |
| 2023-12-31 |
$14,114 |
| 2023-09-30 |
$14,069 |
| 2023-06-30 |
$14,353 |
| 2023-03-31 |
$13,792 |
| 2022-12-31 |
$13,704 |
| 2022-09-30 |
$13,279 |
| 2022-06-30 |
$13,803 |
| 2022-03-31 |
$14,631 |
| 2021-12-31 |
$15,990 |
| 2021-09-30 |
$15,759 |
| 2021-06-30 |
$16,825 |
| 2021-03-31 |
$17,186 |
| 2020-12-31 |
$17,762 |
| 2020-09-30 |
$18,150 |
| 2020-06-30 |
$17,306 |
| 2020-03-31 |
$16,965 |
| 2019-12-31 |
$15,742 |
| 2019-09-30 |
$15,824 |
| 2019-06-30 |
$12,925 |
| 2019-03-31 |
$11,184 |
| 2018-12-31 |
$13,153 |
| 2018-09-30 |
$13,286 |
| 2018-06-30 |
$15,105 |
| 2018-03-31 |
$15,412 |
| 2017-12-31 |
$14,605 |
| 2017-09-30 |
$16,288 |
| 2017-06-30 |
$15,484 |
| 2017-03-31 |
$15,497 |
| 2016-12-31 |
$16,726 |
| 2016-09-30 |
$17,007 |
| 2016-06-30 |
$17,797 |
| 2016-03-31 |
$17,181 |
| 2015-12-31 |
$17,499 |
| 2015-09-30 |
$14,438 |
| 2015-06-30 |
$11,708 |
| 2015-03-31 |
$13,120 |
| 2014-12-31 |
$10,113 |
| 2014-09-30 |
$6,779 |
| 2014-06-30 |
$7,012 |
| 2014-03-31 |
$6,376 |
| 2013-12-31 |
$7,771 |
| 2013-09-30 |
$8,565 |
| 2013-06-30 |
$8,829 |
| 2013-03-31 |
$9,007 |
| 2012-12-31 |
$8,574 |
| 2012-09-30 |
$8,393 |
| 2012-06-30 |
$9,545 |
| 2012-03-31 |
|
| 2011-12-31 |
$10,119 |
| 2011-09-30 |
|
| 2011-06-30 |
$11,487 |
| 2011-03-31 |
|
| 2010-12-31 |
|
| 2010-09-30 |
$11,128 |
| 2010-06-30 |
|
| 2010-03-31 |
|
| 2009-12-31 |
|
| 2009-09-30 |
|
| 2009-06-30 |
|
| 2009-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
